Patient survival after in-hospital cardiac arrest improved substantially in recent years, according to a report from a large registry published online Nov. 15 in the New England Journal of Medicine. Moreover, the rate of clinically significant neurologic disability among survivors has not risen correspondingly; in fact, it also decreased during the same time period, said […]
Young adult carriers of the presenilin gene mutation that invariably induces Alzheimer’s disease around the age of 45 years already show distinctive changes on functional and structural brain MRI and in amyloid-beta biomarkers when they are in their 20s and are still asymptomatic. However, amyloid-beta deposition in the grey matter of the brain does not […]
The imaging agent florbetapir F 18 injection (Amyvid), used to exclude a diagnosis of Alzheimer’s disease, is being evaluated for Medicare reimbursement, the Centers for Medicare and Medicaid Services has announced. The agency stated on Oct. 9 that it expected a preliminary decision by July 2013, and a final decision by October 2013.
Brief low-temperature radiofrequency rhizolysis of the C-1 spinal nerve and C-2 and C-3 dorsal root ganglia was safe and effective for occipital neuralgia with migraine in a retrospective series of 10 patients. “The pain reduction lasted for an average of 5½ months. That’s a longer duration of action than with nerve blockade alone,” said Dr. […]
Recent discoveries in epigenetics could soon make a clinical difference for children with attention-deficit/hyperactivity disorder, autism spectrum disorder, and other conditions, according to an expert.